Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of Accenture plc from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Accenture plc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q1 2010 to Q3 2025.
  • Accenture plc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Aug 2025 was $32.2B, a 10.5% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Accenture plc Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $32.2B +$3.07B +10.5% 31 Aug 2025 10-K 10 Oct 2025
Q2 2025 $31.5B +$2.93B +10.2% 31 May 2025 10-Q 20 Jun 2025
Q1 2025 $30.2B +$2.23B +7.96% 28 Feb 2025 10-Q 20 Jun 2025
Q4 2024 $30.1B +$2.62B +9.52% 30 Nov 2024 10-Q 20 Mar 2025
Q3 2024 $29.2B +$2.71B +10.2% 31 Aug 2024 10-K 10 Oct 2025
Q2 2024 $28.6B +$2.56B +9.81% 31 May 2024 10-Q 20 Jun 2025
Q1 2024 $28B +$3.5B +14.3% 29 Feb 2024 10-Q 20 Jun 2025
Q4 2023 $27.5B +$3.82B +16.1% 30 Nov 2023 10-Q 20 Mar 2025
Q3 2023 $26.5B +$3.71B +16.3% 31 Aug 2023 10-K 10 Oct 2025
Q2 2023 $26.1B +$4.05B +18.4% 31 May 2023 10-Q 20 Jun 2024
Q1 2023 $24.5B +$3.3B +15.6% 28 Feb 2023 10-Q 20 Jun 2024
Q4 2022 $23.7B +$2.73B +13% 30 Nov 2022 10-Q 21 Mar 2024
Q3 2022 $22.7B +$2.65B +13.2% 31 Aug 2022 10-K 10 Oct 2025
Q2 2022 $22B +$2.12B +10.6% 31 May 2022 10-Q 22 Jun 2023
Q1 2022 $21.2B +$2.31B +12.3% 28 Feb 2022 10-Q 22 Jun 2023
Q4 2021 $20.9B +$2.51B +13.6% 30 Nov 2021 10-Q 23 Mar 2023
Q3 2021 $20.1B +$2.6B +14.8% 31 Aug 2021 10-K 10 Oct 2024
Q2 2021 $19.9B +$3.41B +20.7% 31 May 2021 10-Q 23 Jun 2022
Q1 2021 $18.8B +$2.92B +18.4% 28 Feb 2021 10-Q 23 Jun 2022
Q4 2020 $18.4B +$2.83B +18.1% 30 Nov 2020 10-Q 17 Mar 2022
Q3 2020 $17.5B +$2.67B +18% 31 Aug 2020 8-K 30 Sep 2024
Q2 2020 $16.5B +$2.34B +16.6% 31 May 2020 10-Q 24 Jun 2021
Q1 2020 $15.9B +$2.19B +16% 29 Feb 2020 10-Q 24 Jun 2021
Q4 2019 $15.6B +$2.55B +19.5% 30 Nov 2019 10-Q 18 Mar 2021
Q3 2019 $14.8B +$4.1B +38.3% 31 Aug 2019 10-K 12 Oct 2022
Q2 2019 $14.1B +$3.99B +39.3% 31 May 2019 10-Q 25 Jun 2020
Q1 2019 $13.7B +$3.29B +31.5% 28 Feb 2019 10-Q 25 Jun 2020
Q4 2018 $13.1B +$3.16B +32% 30 Nov 2018 10-Q 19 Mar 2020
Q3 2018 $10.7B +$1.01B +10.4% 31 Aug 2018 10-K 15 Oct 2021
Q2 2018 $10.2B +$1.28B +14.4% 31 May 2018 10-Q 27 Jun 2019
Q1 2018 $10.4B +$1.82B +21.2% 28 Feb 2018 10-Q 27 Jun 2019
Q4 2017 $9.89B +$1.86B +23.1% 30 Nov 2017 10-Q 28 Mar 2019
Q3 2017 $9.71B +$1.52B +18.6% 31 Aug 2017 10-K 22 Oct 2020
Q2 2017 $8.88B +$1.17B +15.2% 31 May 2017 10-Q 22 Jun 2017
Q1 2017 $8.62B +$1.24B +16.8% 28 Feb 2017 10-Q 23 Mar 2017
Q4 2016 $8.03B +$1.63B +25.4% 30 Nov 2016 10-Q 21 Dec 2016
Q3 2016 $8.19B +$1.54B +23.2% 31 Aug 2016 10-K 29 Oct 2019
Q2 2016 $7.71B +$1.24B +19.2% 31 May 2016 10-Q 23 Jun 2016
Q1 2016 $7.37B +$824M +12.6% 29 Feb 2016 10-Q 24 Mar 2016
Q4 2015 $6.41B +$389M +6.47% 30 Nov 2015 10-Q 17 Dec 2015
Q3 2015 $6.65B +$362M +5.76% 31 Aug 2015 10-K 24 Oct 2018
Q2 2015 $6.47B +$321M +5.22% 31 May 2015 10-Q 25 Jun 2015
Q1 2015 $6.55B +$763M +13.2% 28 Feb 2015 10-Q 26 Mar 2015
Q4 2014 $6.02B +$600M +11.1% 30 Nov 2014 10-Q 18 Dec 2014
Q3 2014 $6.29B +$858M +15.8% 31 Aug 2014 10-K 26 Oct 2017
Q2 2014 $6.15B +$335M +5.77% 31 May 2014 10-Q 26 Jun 2014
Q1 2014 $5.79B -$153M -2.58% 28 Feb 2014 10-Q 27 Mar 2014
Q4 2013 $5.42B +$422M +8.46% 30 Nov 2013 10-Q 19 Dec 2013
Q3 2013 $5.43B +$803M +17.4% 31 Aug 2013 10-K 28 Oct 2016
Q2 2013 $5.81B +$1.22B +26.6% 31 May 2013 10-Q 28 Jun 2013
Q1 2013 $5.94B +$947M +19% 28 Feb 2013 10-Q 28 Mar 2013
Q4 2012 $4.99B +$775M +18.4% 30 Nov 2012 10-Q 20 Dec 2012
Q3 2012 $4.62B +$274M +6.29% 31 Aug 2012 10-K 30 Oct 2015
Q2 2012 $4.59B +$412M +9.86% 31 May 2012 10-Q 29 Jun 2012
Q1 2012 $4.99B +$945M +23.4% 29 Feb 2012 10-Q 23 Mar 2012
Q4 2011 $4.22B +$908M +27.4% 30 Nov 2011 10-Q 20 Dec 2011
Q3 2011 $4.35B +$1.08B +32.9% 31 Aug 2011 10-K 24 Oct 2014
Q2 2011 $4.18B +$715M +20.7% 31 May 2011 10-Q 24 Jun 2011
Q1 2011 $4.05B +$607M +17.6% 28 Feb 2011 10-Q 25 Mar 2011
Q4 2010 $3.31B 30 Nov 2010 10-Q 20 Dec 2010
Q3 2010 $3.27B 31 Aug 2010 10-K 29 Oct 2013
Q2 2010 $3.46B 31 May 2010 10-Q 25 Jun 2010
Q1 2010 $3.44B 28 Feb 2010 10-Q 26 Mar 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.